Breton Hill Capital Ltd. raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 38.0% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 8,496 shares of the healthcare conglomerate’s stock after buying an additional 2,340 shares during the period. Breton Hill Capital Ltd.’s holdings in UnitedHealth Group were worth $1,575,000 at the end of the most recent quarter.
Several other hedge funds have also made changes to their positions in UNH. Jackson Grant Investment Advisers Inc. raised its stake in UnitedHealth Group by 0.4% in the first quarter. Jackson Grant Investment Advisers Inc. now owns 1,097 shares of the healthcare conglomerate’s stock worth $180,000 after buying an additional 4 shares during the period. Adirondack Trust Co. raised its stake in UnitedHealth Group by 0.5% in the first quarter. Adirondack Trust Co. now owns 990 shares of the healthcare conglomerate’s stock worth $162,000 after buying an additional 5 shares during the period. RB Capital Management LLC raised its stake in UnitedHealth Group by 0.4% in the second quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock worth $321,000 after buying an additional 7 shares during the period. Altfest L J & Co. Inc. raised its stake in UnitedHealth Group by 0.3% in the second quarter. Altfest L J & Co. Inc. now owns 2,963 shares of the healthcare conglomerate’s stock worth $549,000 after buying an additional 10 shares during the period. Finally, Parkside Financial Bank & Trust raised its stake in UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 12 shares during the period. Hedge funds and other institutional investors own 86.21% of the company’s stock.
UnitedHealth Group Incorporated (UNH) traded down 0.28% on Wednesday, reaching $194.24. 718,466 shares of the company’s stock were exchanged. The firm has a 50-day moving average price of $190.68 and a 200-day moving average price of $176.29. UnitedHealth Group Incorporated has a 1-year low of $132.39 and a 1-year high of $196.04. The company has a market capitalization of $187.80 billion, a P/E ratio of 23.33 and a beta of 0.64.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating analysts’ consensus estimates of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business had revenue of $50.05 billion for the quarter, compared to analysts’ expectations of $49.97 billion. During the same period in the previous year, the business earned $1.96 earnings per share. The company’s revenue was up 7.7% on a year-over-year basis. Equities research analysts expect that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be given a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.54%. The ex-dividend date is Thursday, September 7th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.13%.
COPYRIGHT VIOLATION NOTICE: “Breton Hill Capital Ltd. Acquires 2,340 Shares of UnitedHealth Group Incorporated (UNH)” was published by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this report on another domain, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The correct version of this report can be read at https://stocknewstimes.com/2017/08/23/breton-hill-capital-ltd-acquires-2340-shares-of-unitedhealth-group-incorporated-unh.html.
A number of research firms recently weighed in on UNH. Jefferies Group LLC reissued a “buy” rating and issued a $192.00 price objective on shares of UnitedHealth Group in a research report on Friday, May 19th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $201.00 target price on the stock in a research note on Wednesday, June 7th. Barclays PLC upped their target price on shares of UnitedHealth Group from $200.00 to $217.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 19th. Cowen and Company restated a “buy” rating on shares of UnitedHealth Group in a research note on Friday, July 14th. Finally, Leerink Swann restated an “outperform” rating on shares of UnitedHealth Group in a research note on Friday, June 9th. One equities research analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $203.41.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $178.74, for a total value of $990,219.60. Following the sale, the director now directly owns 60,516 shares in the company, valued at $10,816,629.84. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total transaction of $913,200.00. Following the completion of the sale, the director now owns 75,735 shares in the company, valued at $13,832,240.40. The disclosure for this sale can be found here. Over the last quarter, insiders sold 30,540 shares of company stock worth $5,748,970. 0.89% of the stock is owned by company insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.
